*001944643
*00520200803141605.0
*007ta
*008191031s2019    no a   e m    00  0 eng
*00901653nam a2200325 c 4500
*019  $bl
*020  $a9788283775174$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999920933377902201
*035  $a(NO-LaBS)15143356(bibid)
*040  $aNO-OsNB$bnob$erda
*060 4$aQV 193
*1001 $aSchultz, Nina Haagenrud$d1971-$0(NO-TrBIB)1581514961650$4aut$_119460100
*24510$aOral factor Xa inhibitors :$bstudies on reversal of their anticoagulant effect and on their influence on primary hemostasis, endothelial function and fibrinolysis$cNina Haagenrud Schultz
*264 1$a[Oslo]$bFaculty of Medicine, University of Oslo$c2019
*300  $a1 bind (varierende paginering)$billustrasjoner$c24 cm
*336  $atekst$0http://rdaregistry.info/termList/RDAContentType/1020$2rdaco
*337  $auformidlet$0http://rdaregistry.info/termList/RDAMediaType/1007$2rdamt
*338  $abind$0http://rdaregistry.info/termList/RDACarrierType/1049$2rdact
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling ph.d.) - Universitetet i Oslo, 2019
*650 2$aAnticoagulants$0(DNLM)D000925$_119460200
*650 2$aBlood Coagulation Factors$xdrug effects$0(DNLM)D001779Q000187$_119460300
*650 2$aFactor Xa Inhibitors$0(DNLM)D065427$_119460400
*7102 $aUniversitetet i Oslo$bDet medisinske fakultet$0(NO-TrBIB)90302138$4pbl$_10213300
*7102 $aUniversitetet i Oslo$bInstitutt for klinisk medisin$0(NO-TrBIB)15000758$4dgg$_10213400
*830 0$aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo$x1502-9921$w990122483394702201$_204428600
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999920016068202202$b2021-11-14T21:08:46Z$z999920016068202202
^